The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.
about
Signaling by the phosphoinositide 3-kinase family in immune cellsFuture therapeutic targets in rheumatoid arthritis?The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation.Lipid signaling in T-cell development and functionPI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).PI3Ks in lymphocyte signaling and developmentPhosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury.The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic DiseasesAll PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells.PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advancesPI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases.Leukotriene B4 mediates gammadelta T lymphocyte migration in response to diverse stimuli.Does the PI3K pathway promote or antagonize regulatory T cell development and function?PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma.Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels.PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment.Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome.
P2860
Q28283677-040C23E4-226C-4F32-8571-0C1A5834B8D8Q33841419-A7033988-0C4F-49B0-A815-ADB7A5B9F7EDQ33855380-1AD5AD89-CE1B-4A50-84D9-340A5CC58412Q34241131-30D20DF1-B6B6-4E78-A061-E5130224DBB4Q34428066-B75A159E-0E42-4E8B-9634-EFA630A38E0AQ34582117-44121D68-929F-45E7-8360-961AC2FB2B37Q35843746-D195BACD-BE9B-43DA-811E-F76976D8079DQ35876779-9673CD30-5440-4A4E-AB1C-3E29FE7B7FB5Q36286414-714CB395-1C49-4426-9C5F-0315B178FA9FQ36303948-D1C54E85-BCB9-4DB9-9AFB-A417F9D0CE6BQ36516932-697204B6-6D24-422F-B05F-8984A99B3F3CQ37951937-258D34CE-4E97-44EF-8246-19A9D301EA34Q38034501-21622BEF-024F-4A8F-8F42-0094C506A906Q40708110-3A1B354B-52CA-40BC-94B1-F3E73C027A03Q41864874-47843F37-8C2B-4DB9-8969-D024A8AFCA7DQ41994564-258CC3F1-088D-4CD7-B4FE-11A6950F7A96Q42206056-B3C9A17C-85E4-43C4-93F9-CF8556676F4FQ47210902-4268CFFE-5DF4-4C04-BADD-83902FE40978Q47794089-5C1A6475-BF1E-4115-BA07-1ACC2A7DC4DBQ51738230-725BE90F-D5B3-47CF-8BA4-886B751B8278Q54615874-EF94A508-24A6-4D49-B8B1-E191DF7B12F1
P2860
The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The p110gamma isoform of phosp ...... peripheral inflammatory sites.
@en
type
label
The p110gamma isoform of phosp ...... peripheral inflammatory sites.
@en
prefLabel
The p110gamma isoform of phosp ...... peripheral inflammatory sites.
@en
P2093
P2860
P356
P1476
The p110gamma isoform of phosp ...... peripheral inflammatory sites
@en
P2093
Amanda L Martin
Christopher C DeNucci
Jason S Mitchell
Molly S Thomas
P2860
P304
P356
10.1189/JLB.0807561
P50
P577
2008-06-03T00:00:00Z